These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16307510)

  • 1. Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?
    Rothel JS; Andersen P
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):981-93. PubMed ID: 16307510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of latent tuberculosis infection: the potential role of new technologies.
    Kunst H
    Respir Med; 2006 Dec; 100(12):2098-106. PubMed ID: 16650976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts].
    Oztürk N; Sürücüoğlu S; Ozkütük N; Gazi H; Akçali S; Köroğlu G; Ciçek C
    Mikrobiyol Bul; 2007 Apr; 41(2):193-202. PubMed ID: 17682705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay.
    Winje BA; Oftung F; Korsvold GE; Mannsåker T; Ly IN; Harstad I; Dyrhol-Riise AM; Heldal E
    BMC Infect Dis; 2008 Oct; 8():140. PubMed ID: 18928541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regions of differences encoded antigens as targets for immunodiagnosis of tuberculosis in humans.
    Parkash O; Singh BP; Pai M
    Scand J Immunol; 2009 Oct; 70(4):345-57. PubMed ID: 19751269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel screening tools for latent tuberculosis: time to leave an old friend?
    Villiger PM; Zellweger JP; Möller B
    Curr Opin Rheumatol; 2009 May; 21(3):238-43. PubMed ID: 19346950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis.
    Pai M; Kalantri S; Dheda K
    Expert Rev Mol Diagn; 2006 May; 6(3):413-22. PubMed ID: 16706743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test.
    Lighter J; Rigaud M; Eduardo R; Peng CH; Pollack H
    Pediatrics; 2009 Jan; 123(1):30-7. PubMed ID: 19117857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell-based diagnosis of childhood tuberculosis infection.
    Lalvani A; Millington KA
    Curr Opin Infect Dis; 2007 Jun; 20(3):264-71. PubMed ID: 17471036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agreement between Mantoux skin testing and QuantiFERON-TB assay using dual mycobacterial antigens in current and former injection drug users.
    Shah SS; McGowan JP; Klein RS; Converse PJ; Blum S; Gourevitch MN
    Med Sci Monit; 2006 Apr; 12(4):MT11-6. PubMed ID: 16572060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases.
    Soborg B; Ruhwald M; Hetland ML; Jacobsen S; Andersen AB; Milman N; Thomsen VO; Jensen DV; Koch A; Wohlfahrt J; Ravn P
    J Rheumatol; 2009 Sep; 36(9):1876-84. PubMed ID: 19648300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of an in vitro tuberculosis interferon-gamma assay with delayed-type hypersensitivity testing for detection of latent Mycobacterium tuberculosis: a pilot study in rheumatoid arthritis.
    Greenberg JD; Reddy SM; Schloss SG; Kurucz OS; Bartlett SJ; Abramson SB; Bingham CO
    J Rheumatol; 2008 May; 35(5):770-5. PubMed ID: 18322990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New tools for detection of latent tuberculosis].
    Restrepo BI
    Biomedica; 2004 Jun; 24 Supp 1():202-11. PubMed ID: 15495587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QuantiFERON-TB Gold assay for the diagnosis of latent tuberculosis infection.
    Manuel O; Kumar D
    Expert Rev Mol Diagn; 2008 May; 8(3):247-56. PubMed ID: 18598104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved efficiency in detecting cellular immunity towards M. tuberculosis in patients receiving immunosuppressive drug therapy.
    Sester U; Junker H; Hodapp T; Schütz A; Thiele B; Meyerhans A; Köhler H; Sester M
    Nephrol Dial Transplant; 2006 Nov; 21(11):3258-68. PubMed ID: 16935889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.
    Codecasa L; Mantegani P; Galli L; Lazzarin A; Scarpellini P; Fortis C
    J Clin Microbiol; 2006 Jun; 44(6):1944-50. PubMed ID: 16757583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and diagnosis of Mycobacterium tuberculosis.
    Al-Zamel FA
    Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1099-108. PubMed ID: 19883330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.